Nikolai Albert

Nikolai Albert

Auto-generated profile, based on publicly available information

Nikolai Albert

Copenhagen Research Center for Mental Health (CORE), Mental Health Centre Copenhagen, Copenhagen University Hospital – Mental Health Services CPH , 2900 Hellerup

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Schizophrenia Research
Verified
Journal Article
Closed access
SAStephen F Austin
Stephen F Austin
OMOle Mors
Ole Mors
RSRikke Gry Secher
Rikke Gry Secher
CHCarsten R. Hjorthøj
Carsten R. Hjorthøj
NANikolai Albert
Nikolai Albert
MNMerete Nordentoft
Merete Nordentoft

1 February 2011 in Schizophrenia Research
Verified
Journal Article
Closed access
NANikolai Albert
Nikolai Albert
MBMette Bertelsen
Mette Bertelsen
ATAnne Thorup
Anne Thorup
LPLone Petersen
Lone Petersen
PJPia Jeppesen
Pia Jeppesen
MNMerete Nordentoft
Merete Nordentoft

1 January 2014 in European Psychiatry
Verified
Journal Article
Closed access
ATA. Thorup
A. Thorup
NAN. Albert
N. Albert
MBM. Bertelsen
M. Bertelsen
LPL. Petersen
L. Petersen
PJP. Jeppesen
P. Jeppesen
MNM. Nordentoft
M. Nordentoft
Objective: Gender differences in psychosis have been investigated, and the results have contributed to a better understanding of the disease, but many questions are unanswered. In clinical terms, women and men with psychosis differ in terms of access to social support, tendency of substance abuse, level of functioning and symptom patterns. We aimed to investigate how gender differences at onset of psychosis develop during the first 5 years of treatment.Method: A total of 578 patients with a first-episode psychosis in the schizophrenia spectrum were included in the Danish OPUS trial – a randomized clinical trial comparing 2 years of intensive early-intervention programme with standard treatment. All patients were assessed with validated instruments at inclusion, and after 2 and 5 years. Data were analysed for significant gender differences.Results: Males have significantly higher levels of negative symptoms at all times, and are more likely to live alone and suffer from substance abuse. Females reach higher levels of social functioning at follow-up, and show a greater tendency to be employed or in education than males. Markedly more women than men live with children. More women than men reach a state of recovery and are more compliant with medication.Conclusion: There are significant gender differences at 2- and 5-year follow-up in this large cohort of first-episode psychotic patients. Males and females show different symptomatology and different levels of social functioning.

1 April 2017 in Schizophrenia Research
Verified
Journal Article
Closed access
RWRegitze Sølling Wils
Regitze Sølling Wils
DGDitte Resendal Gotfredsen
Ditte Resendal Gotfredsen
CHCarsten Hjorthøj
Carsten Hjorthøj
SAStephen F Austin
Stephen F Austin
NANikolai Albert
Nikolai Albert
MNMerete Nordentoft
Merete Nordentoft

12 January 2017 in BMJ
Verified
Journal Article
Open access
PDF file
NANikolai Albert
Nikolai Albert
MMMarianne Melau
Marianne Melau
HJHeidi Jensen
Heidi Jensen
CECharlotte Emborg
Charlotte Emborg
JJJens Richardt Mollegaard Jepsen
Jens Richardt Mollegaard Jepsen
MNMerete Nordentoft
Merete Nordentoft
Objective To compare the effects of five years of specialised early intervention (SEI) treatment for first episode schizophrenia spectrum disorder with the standard two years of SEI plus three years of treatment as usual. Design Randomised, superiority, parallel group trial with blinded outcome assessment. Randomisation was centralised and computerised with concealed randomisation sequence carried out at an external site. Setting Participants were recruited from six OPUS teams in Denmark between 2009 and 2012. OPUS teams provide SEI treatment to all patients diagnosed with a schizophrenia spectrum disorder in Denmark. Participants 400 participants (51% women) with a mean age of 25.6 (standard deviation 4.3) were randomised to five years of SEI (experimental intervention; n=197) or to two years of SEI plus three years of treatment as usual (control; n=203). Interventions OPUS treatment consists of three core elements—modified assertive community treatment, family involvement, and social skill training—with a patient-case manager ratio of no more than 12:1. For participants randomised to five years of OPUS treatment, the treatment was largely unchanged. Participants randomised to the control group were mostly referred to community health centres after two years of SEI treatment. Main outcomes Follow-up assessments were conducted five years after start of OPUS treatment. Primary outcome was negative symptoms measured on the scale for assessment of negative symptoms (avolition-apathy, anhedonia, alogia, and affective blunting). Secondary outcomes were remission of both negative and psychotic symptoms, psychotic symptoms, suicidal ideation, substance abuse, compliance with medical treatment, adherence with treatment, client satisfaction, days in hospital care, and labour market affiliation. Results Levels of negative symptoms did not differ between the intervention group and control group (1.72 v 1.81 points; estimated mean difference −0.10 (95% confidence interval 0.33 to 0.13), P=0.39). Participants receiving five years of OPUS treatment were more likely to remain in contact with specialised mental health services (90.4% v 55.6%, P<0.001), had higher client satisfaction (estimated mean difference 2.57 points (95% confidence interval 1.36 to 3.79), P<0.001), and had a stronger working alliance (estimated mean difference 5.56 points (95% confidence interval 2.30 to 8.82), P=0.001) than the control group. Conclusions This trial tests SEI treatment for up to five years for patients with first episode schizophrenia spectrum disorder; previous trials have found treatment effects for programmes lasting from one to three years. The prolonged SEI treatment had few effects, which could be due to the high level of treatment provided to control participants and the late start of specialised treatment. Trial registration Clinicaltrial.gov NCT00914238.

26 September 2017 in Schizophrenia
Verified
Journal Article
Open access
PDF file
NANikolai Albert
Nikolai Albert
MMMarianne Melau
Marianne Melau
HJHeidi Jensen
Heidi Jensen
LHLene Halling Hastrup
Lene Halling Hastrup
CHCarsten Hjorthøj
Carsten Hjorthøj
MNMerete Nordentoft
Merete Nordentoft
The duration of untreated psychosis (DUP) has been shown to have an effect on outcome after first-episode psychosis. The premise of specialized early intervention (SEI) services is that intervention in the early years of illness can affect long-term outcomes. In this study, we investigate whether DUP affects treatment response after 5 years of SEI treatment compared to 2 years of SEI treatment. As part of a randomized controlled trial testing the effect of prolonged SEI treatment 400 participants diagnosed within the schizophrenia spectrum were recruited. For this specific study participants were dichotomized based on DUP, treatment delay, and time from first symptom until start of SEI treatment. The groups were analyzed with regard to treatment response on psychopathology, level of functioning, and cognitive functioning. The participants with a short DUP had a tendency to respond better to the prolonged treatment with regards to disorganized and negative dimension. For participants with short duration from first symptom until start of SEI treatment there was a significant difference on the negative dimension favoring the prolonged OPUS treatment. The finding of an effect of prolonged treatment for participants with a short total treatment delay could mean that prolonged SEI treatment is more beneficial than treatment as usual (TAU) so long as it is provided in the early years of illness and not just in the early years after diagnosis.